"This is the best use of my time to remain current with what is going on in the industry."
WHO WE ARE
The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.
NOT A MEMBER?
The goal is to produce a list and description of the essential metadata required to be able to reenact the events of the trial.
Questions from eSRA Users
This is a categorised list of questions sent in from eSRA users (sites, sponsors, CROs) with the response from the eClinical Forum eSRA Team.
eClinical Forum has released the 2024 version of their “eSource Readiness Assessment” – eSRA
It is a response to the growing expectation by regulatory agencies for clinical trial sponsors to verify that clinical research site systems (e.g., EHRs) comply with requirements to protect confidentiality and provide accurate and reliable data for the use in a regulated research environment. V2024 includes updates based on the EMA Guideline on computerised systems and electronic data in clinical trials.
eCF Birds-of-a-Feather Webinar: EHR-EDC Integration – Implementation Overview and Learnings
Implementing EHR-EDC integrations is an emerging area of focus in the pharma industry. This presentation will share an overview of implementing an EHR-EDC integration on 2 studies and the associated lessons learned. Following this overview will be a group discussion on such integrations and prospects for broader adoption within our clinical trials.
eCF Spring Workshop in Zurich, Switzerland
This workshop is hosted by BSI Life Sciences at their office in Zurich, Switzerland on April 16-18. It will also be live-streamed and recorded for access by all eCF members.
eCF Spring Workshops Announced
Europe/Global hybrid workshop -- April 16-18
Americas in-person workshop -- April 30 - May 2
eCF Spring Workshop in Ridgefield, Connecticut USA
Registration is open for the eCF Spring Workshop, kindly hosted by Boehringer Ingelheim at their Ridgefield, Connecticut campus on April 30 to May 3, 2024.